Philippe Gérard
Philippe Gérard
INRA Micalis Institute
Dirección de correo verificada de
Citado por
Citado por
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
T Le Roy, M Llopis, P Lepage, A Bruneau, S Rabot, C Bevilacqua, ...
Gut 62 (12), 1787-1794, 2013
Germ‐free C57BL/6J mice are resistant to high‐fat‐diet‐induced insulin resistance and have altered cholesterol metabolism
S Rabot, M Membrez, A Bruneau, P Gérard, T Harach, M Moser, ...
The FASEB Journal 24 (12), 4948-4959, 2010
Metabolism of cholesterol and bile acids by the gut microbiota
P Gérard
Pathogens 3 (1), 14-24, 2013
Gut microbiota and obesity
P Gérard
Cellular and molecular life sciences 73 (1), 147-162, 2016
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
M Llopis, AM Cassard, L Wrzosek, L Boschat, A Bruneau, G Ferrere, ...
Gut 65 (5), 830-839, 2016
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)
Z Safari, P Gérard
Cellular and Molecular Life Sciences 76, 1541-1558, 2019
Microbial Community Development in a Dynamic Gut Model Is Reproducible, Colon Region Specific, and Selective for Bacteroidetes and Clostridium Cluster IX
P Van den Abbeele, C Grootaert, M Marzorati, S Possemiers, ...
Applied and environmental microbiology 76 (15), 5237-5246, 2010
Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin‐degradation in humanized rats
P Van den Abbeele, P Gérard, S Rabot, A Bruneau, S El Aidy, M Derrien, ...
Environmental microbiology 13 (10), 2667-2680, 2011
Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance
T Clavel, C Desmarchelier, D Haller, P Gérard, S Rohn, P Lepage, ...
Gut microbes 5 (4), 544-551, 2014
The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism
S Just, S Mondot, J Ecker, K Wegner, E Rath, L Gau, T Streidl, ...
Microbiome 6, 1-18, 2018
Microbial impact on cholesterol and bile acid metabolism: current status and future prospects
A Kriaa, M Bourgin, A Potiron, H Mkaouar, A Jablaoui, P Gérard, ...
Journal of lipid research 60 (2), 323-332, 2019
Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier
M Van Hul, L Geurts, H Plovier, C Druart, A Everard, M Ståhlman, M Rhimi, ...
American Journal of Physiology-Endocrinology and Metabolism 314 (4), E334-E352, 2018
The intestinal microbiota regulates host cholesterol homeostasis
T Le Roy, E Lécuyer, B Chassaing, M Rhimi, M Lhomme, S Boudebbouze, ...
BMC biology 17 (1), 1-18, 2019
Bacteroides sp. Strain D8, the First Cholesterol-Reducing Bacterium Isolated from Human Feces
P Gérard, P Lepercq, M Leclerc, F Gavini, P Raibaud, C Juste
Applied and environmental microbiology 73 (18), 5742-5749, 2007
High fat diet drives obesity regardless the composition of gut microbiota in mice
S Rabot, M Membrez, F Blancher, B Berger, D Moine, L Krause, R Bibiloni, ...
Scientific reports 6 (1), 32484, 2016
Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice
F Respondek, P Gerard, M Bossis, L Boschat, A Bruneau, S Rabot, ...
PloS one 8 (8), e71026, 2013
Interplay between exercise and gut microbiome in the context of human health and performance
M Clauss, P Gérard, A Mosca, M Leclerc
Frontiers in nutrition 8, 637010, 2021
Rapid analysis of bile acids in different biological matrices using LC-ESI-MS/MS for the investigation of bile acid transformation by mammalian gut bacteria
K Wegner, S Just, L Gau, H Mueller, P Gérard, P Lepage, T Clavel, ...
Analytical and Bioanalytical Chemistry 409, 1231-1245, 2017
Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease
N Fei, A Bruneau, X Zhang, R Wang, J Wang, S Rabot, P Gérard, L Zhao
MBio 11 (1), 10.1128/mbio. 03263-19, 2020
Correlation between faecal microbial community structure and cholesterol-to-coprostanol conversion in the human gut
P Veiga, C Juste, P Lepercq, K Saunier, F Béguet, P Gérard
FEMS microbiology letters 242 (1), 81-86, 2005
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20